Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Human Immunology Year : 2010

Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation.

Abstract

Anti-HLA antibody (Ab) monitoring is essential for the follow-up of transplant patients. However, it can be affected by drugs, especially Ab infused as a conditioning regimen for transplantation. ATG Fresenius, commonly used in this setting, is a polyclonal rabbit Ab raised against the Jurkat human T cell line (HLA-A3, 32; B7, 35). We report here the de novo detection by CDC and flow cytometry (Luminex) of anti-HLA-A3 Ab in the serum of kidney recipients treated with ATG Fresenius. The Ab, of rabbit origin, was detected in every assessable patient (n = 16), with the exception of the HLA-A3 recipients and/or recipients receiving an HLA-A3 graft, before becoming undetectable, at latest, at day 102 after transplantation. It is of major importance that transplantation monitoring laboratories bear in mind the possibility of therapeutic Ab detection when interpreting anti-HLA Ab results.

Domains

Immunology

Dates and versions

inserm-00484267 , version 1 (18-05-2010)

Identifiers

Cite

Emeline Masson, Nadège Devillard, Jacqueline Chabod, Maria Yannaraki, Chantal Thevenin, et al.. Misleading de novo detection of serum anti-HLA-A3 antibodies in kidney recipients having received ATG before transplantation.. Human Immunology, 2010, 71 (2), pp.170-5. ⟨10.1016/j.humimm.2009.11.003⟩. ⟨inserm-00484267⟩

Collections

INSERM UNIV-FCOMTE
98 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More